Together Pharma – Vision, action, and message for consumers of medical cannabis
|The company manages a highly advanced agricultural system that enables supervision of the cannabis using the most advanced technologies|
|Nir Sosinsky, Partner and co-CEO of Globus Pharma firstname.lastname@example.org|
|October 22, 2019|
Together Pharma is a company engaged in the development of a variety of cannabis strains for medicinal purposes, including cultivating the plants, and producing and distributing medicinal cannabis products: inflorescence, capsules, oils, cookies and more.
The company manages a highly advanced agricultural system that enables supervision of the cannabis using the most advanced technologies. Currently, the company owns two growing farms, one in Israel and the second one in Uganda, where our employees diligently oversee the development of high quality, medical-grade cannabis plants that meet not only the stringent Israeli Ministry of Health standards, but also those of the medical bodies in the European countries to where the company is interested in exporting its products.
The majority of cultivation takes place in greenhouses and used the most advanced technologies under the support of expert agronomists. The company's products are manufactured in pharmaceutical factory clean rooms, under stringent control, and subject to the most up-to-date standards, all designed to ensure the supply of outstanding medical products.
The company’s distribution network in Israel is tailored to distribute the final products through pharmacies, as required by the Israeli Ministry of Health and according to its very strict standards. It has also been structured to meet the distribution requirements of exporting products once the export of medical cannabis from Israel will be permitted.
In regard to supplying medical cannabis in other venues, the European market that Together Pharma is aiming to break into still seems to be in its infancy. However, all signs indicate that within a few years, it will prove to be an extensive and very substantial opportunity.
According to Nir Sosinsky, the demand for medicinal cannabis products in existing markets all over the world is growing, and there are those who claim that we are just at the beginning and the horizon appears extremely promising. Prevailing trends indicate that the consumption of inflorescence is giving way to other new products from this wonderful plant: capsules, suppositories, ointments, etc. At Together Pharma, we are attentive to what is going on in the field and are diligently pursuing all possible channels that will expand our activity and attain significant achievements for the benefit of consumers.
The article was published in #2 edition Cannabis2020